Get the Stockscreener App
48.06
3.02%
1.41
Pre-market:
47.71
-0.35
-0.73%
Twist Bioscience Corp stock is traded at $48.06, with a volume of 1.06M.
It is up +3.02% in the last 24 hours and down -0.12% over the past month.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
See More
Previous Close:
$46.65
Open:
$46.92
24h Volume:
1.06M
Relative Volume:
0.81
Market Cap:
$2.95B
Revenue:
$362.27M
Net Income/Loss:
$-85.19M
P/E Ratio:
-33.14
EPS:
-1.45
Net Cash Flow:
$-68.71M
1W Performance:
-3.07%
1M Performance:
-0.12%
6M Performance:
+87.51%
1Y Performance:
+21.12%
1-Day Range:
$46.83
$49.31
1-Week Range:
$42.89
$50.02
52-Week Range:
$23.30
$57.88
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
48.06 | 2.86B | 362.27M | -85.19M | -68.71M | -1.45 |
|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-25 | Initiated | Stephens | Overweight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Twist Bioscience Corp (TWST) Stock Price Up 5.17% on Mar 4 - GuruFocus
Twist Bioscience at TD Cowen Conference: Strategic Expansion in Therapeutics - Investing.com
TWST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Twist Bioscience Corporation $TWST Shares Sold by Vanguard Group Inc. - MarketBeat
The Insider Report: The Two Way Tape Continues as Bears Hold Firm - Sahm
What is the target price for Twist Bioscience Corporation stockJuly 2025 Retail & Weekly High Return Forecasts - baoquankhu1.vn
Assessing Twist Bioscience (TWST) Valuation After Insider Sale And Recent Q1 FY26 Optimism - Yahoo Finance
[Form 4] Twist Bioscience Corp Insider Trading Activity - Stock Titan
Twist Bioscience (TWST) CFO tax-related sale of 2,085 shares disclosed - Stock Titan
Tax withholding sale by Twist Bioscience (TWST) SVP Paula Green - Stock Titan
Tax-withholding sale: Twist Bioscience (TWST) officer disposes 844 shares - Stock Titan
Twist Bioscience Adds Invenra Bispecific Platform To Broaden Discovery Opportunity - Yahoo Finance
Twist Bioscience Corp. Hits Day Low of $46.04 Amid Price Pressure - Markets Mojo
ARK Unplugged: How Cathie Wood Crushed the S&P 500 in 2025 - Benzinga
Dennis H. Cho files Form 144 to sell 844 shares (TWST) - Stock Titan
2,085-Share Rule 144 Notice for Twist Bioscience (NASDAQ: TWST) - Stock Titan
Insider sale notice at TWST (NASDAQ: TWST) — 1,465 shares planned - Stock Titan
Insider sales and restricted stock vesting — TWST (NASDAQ: TWST) - Stock Titan
Robert F. Werner sells TWST shares; restricted 1,693 shares vest (TWST) - Stock Titan
Aug Gainers: Will Twist Bioscience Corporation stock benefit from M A2025 Earnings Impact & Daily Profit Focused Screening - baoquankhu1.vn
Twist Bioscience (TWST) Shares Dip as Executive Sells $2M in Sto - GuruFocus
Twist Bioscience (NASDAQ:TWST) Shares Gap DownWhat's Next? - MarketBeat
Twist Bioscience Corp (TWST) Stock Price Down 6.6% on Feb 20 - GuruFocus
Twist Bioscience stock falls after insider sale (TWST:NASDAQ) - Seeking Alpha
Insider Sell: Paula Green Sells 39,404 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience Corp (TWST) Trading Down 4.44% on Feb 19 - GuruFocus
Twist Bioscience (TWST) COO sells 68,967 shares under 10b5-1 plan - Stock Titan
Twist Bioscience to Present at Upcoming Investor Conferences - Business Wire
Twist Bioscience stock hits 52-week high at $51.02 By Investing.com - Investing.com India
Twist Bioscience enters licensing agreement with Invenra - TipRanks
Twist Bioscience Raises FY26 Revenue Forecast Exceeding Market Expectations - StocksToTrade
Twist Bioscience stock hits 52-week high at $51.02 - Investing.com
Twist Bioscience licenses Invenra’s bispecific antibody platform - Investing.com
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement - Business Wire
Insider Sell: Adam Laponis Sells 7,000 Shares of Twist Bioscience Corp (TWST) - GuruFocus
Twist Bioscience (NASDAQ:TWST) Insider Dennis Cho Sells 5,000 Shares - MarketBeat
Patrick Finn of Twist Bioscience (TWST) files to sell 3,500 shares under Rule 144 - Stock Titan
Insider plans 7,000-share Twist Bioscience (TWST) sale under Form 144 - Stock Titan
Twist Bioscience Corporation (NASDAQ:TWST) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
TWST stock (NASDAQ: TWST) holder plans 5,000-share sale filing - Stock Titan
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes - Business Wire
Twist Bioscience (NASDAQ:TWST) Director Sells $105,402.00 in Stock - MarketBeat
Twist Bioscience Annual Meeting: Shareholders Elect Directors, Approve Pay and EY Auditor Ratification - Yahoo Finance
Twist Bioscience shareholders approve director elections and executive compensation - Investing.com
Twist Bioscience shareholders approve director elections and executive compensation By Investing.com - Investing.com Australia
Twist Bioscience (NASDAQ:TWST) CEO Emily Leproust Sells 5,001 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) CAO Robert Werner Sells 7,000 Shares - MarketBeat
Twist Bioscience (TWST) Valuation After Q1 Beat And Raised 2026 Outlook - simplywall.st
Commit To Purchase Twist Bioscience At $37.50, Earn 27.6% Annualized Using Options - Nasdaq
Twist Bioscience Guidance Lift Puts AI Demand And Risks In Focus - Yahoo Finance
Assessing Twist Bioscience (TWST) Valuation After Recent Share Price Momentum - Yahoo Finance
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
0.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):